@ShadiYaghi2 And fits very nicely the discrepant bleeding in RESPECT ESUS vs Navigate ESUS and in RELY / ARISTOTLE vs NAVIGATE AF. We can almost definitively state, once daily pulsatile dosing is not as safe as a smooth, lower level - donβt use rivaroxaban in AF!
@Carmelo_Tiberio@Ash_Shoamanesh Tirzapetide drops BP around 10mmHg in obese patients - so should reduce ICH at maximally tolerated doses by 30-50%β¦ https://t.co/Go46GgqEiO
Great presentation on treat and transfer optimisation from Marc Ribo at #WSC2024. In an optimised system, the threshold for overall harm from prehospital LVO bypass seems to be at about 60 minutes transfer time.
Congratulations @sheilambrasil on your 2 inspiring and productive years as WSO President. Thank you for your indefatigable efforts to improve stroke care around the globe!
Important presentation and publication from Paul Whelton at #wsc2024. Targeting BP below 130 lowers all cause cvd, stroke and mortality without substantial risk. https://t.co/t3dzvYtRVw
Very proud to be sharing the WSO Angels diamond award with colleagues around the world - on behalf of Lizzie Dodd, Jackson Harvey and the RAH stroke team!
Awesome to see Telestroke in Australia and @AusStroke receive such positive publicity - thanks to @Ch7Adelaide, @PictonChris and @Mark_Butler_MP . Most importantly - thank you Emily for sharing your story! https://t.co/t3Ivwz3kPa
Great to hear that TNK shortages in Australia have now resolved. Especially helpful in Telestroke settings and helping mobile stroke unit roll-outs! https://t.co/Euh9oytbjR
Exciting new potential schizophrenia treatment Kar-XT for positive and negative symptoms. Benefits of increasing cholinergic neurotransmission has interesting parallels in LBD/other dementia psychosis, and fits well with 'total sensory deprivation' as psychosis cause in the well
The TRAIN RCT - interesting study with implications for ICH management - patients with liberal transfusion strategy (<9gm/dL vs <7) had better neurological outcome consistently across TBI, ICH and SAH subgroups. https://t.co/2W8o95t7nH
Thank you Federal Minister Butler for launching the Impact of Stroke report at #APSC24! Looking very much forward to working together to substantially reduce this impactβ¦
Terrific workshop at #APSC24 on the 30/60/90 National Stroke Targets. Simultaneous publication of our national βcall to armsβ in the MJA! https://t.co/gL91nnOxZd
Very excited that https://t.co/MQAxn2gvXH has finally started! Excellent pre-conference workshop day ahead. Thankyou cerebrovascular diseases for publishing our terrific scientific content! https://t.co/DyjzteFihQ
Congrats from Down Under Dr Michael Hill - warmly deserved. Few people are so smart, so productive, so generous and so humane (with such an incredible memory for peoples' names!) Looking forward to seeing you - and hearing you speak - at https://t.co/wVWtXsUIU1
ππΌ Dr. Michael Hill has been recognized by his peers as one of Canadaβs leading researchers in brain health. Thanks @UBCmedicine for honouring Dr. Hillβs commitment to advancing stroke research and treatment on a global scale! @DCNSNeuro@CalDomMed@HotchkissBrain@LibinInstitute
Only six weeks to go until https://t.co/wVWtXsUIU1! The program just keeps getting better and better. Just confirmed - Prof Fabienne Perren (Neurosonology) Prof Avril Drummond and Prof Michael Hill. Register now to secure reduced rates - don't forget our Conference dinner Th pm!
Warmest congrats @DominiqueCad and @AustStrokeReg for achieving Tier One national registry funding! A landmark achievement and culmination of 15 years of grind! https://t.co/CS9U0pxSzb
Thanks to @Anna_Ranta, Chris Bladin @StrokeAus and @CloudDrGeoff for contributing their experience to this article - how to maximise access to optimised stroke care https://t.co/tteOdqgkpi